Old Lyme, CT, United States of America

Michael Jon Gumkowski

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 6.4

ph-index = 3

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 2001-2016

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Michael Jon Gumkowski

Introduction

Michael Jon Gumkowski is a notable inventor based in Old Lyme, Connecticut, with a significant portfolio of eight patents. His work primarily focuses on pharmaceutical compositions, showcasing his expertise in drug formulations and stability.

Latest Patents

Among his latest patents, Gumkowski has developed pharmaceutical compositions that include dispersions of acid-sensitive drugs combined with neutral polymers. This innovation enhances the chemical stability of the drugs compared to those formulated with acidic polymers. Additionally, he has created pharmaceutical compositions for low-solubility drugs that utilize amphiphilic, hydroxy-functional vinyl copolymers. Another significant contribution is his work on pharmaceutical compositions of cholesteryl ester transfer protein inhibitors, which involve solid amorphous dispersions that enhance the concentration of these inhibitors through the use of specific polymers.

Career Highlights

Throughout his career, Gumkowski has worked with prominent companies such as Bend Research, Inc. and Pfizer Corporation. His experience in these organizations has allowed him to contribute to advancements in pharmaceutical technology and drug delivery systems.

Collaborations

Gumkowski has collaborated with several professionals in his field, including Dwayne Thomas Friesen and Douglas Alan Lorenz. These partnerships have likely enriched his research and development efforts.

Conclusion

Michael Jon Gumkowski's innovative work in pharmaceutical compositions has made a significant impact in the field of drug formulation. His contributions continue to advance the stability and effectiveness of various medications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…